Company

genOway SA

Headquarters: Lyon, France

Employees: 121

Euronext: ALGEN +4.28%

Market Cap

€37.3 Million

EUR as of Jan. 1, 2024

US$41.2 Million

Market Cap History

genOway SA market capitalization over time

Evolution of genOway SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of genOway SA

Detailed Description

genOway Société anonyme, a biotechnology company, develops, manufactures, commercializes, and sells of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and immune checkpoint catalog cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was founded in 1999 and is headquartered in Lyon, France.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

genOway SA has the following listings and related stock indices.


Stock: Euronext: ALGEN wb_incandescent

Stock: FSX: JEH wb_incandescent

Details

Headquarters:

Technopark 2

31 Rue Saint Jean-de-Dieu

Lyon, 69007

France

Phone: 33 4 37 65 41 00

Fax: 33 4 37 65 41 01